Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LONCASTUXIMAB TESIRINE-LPYL for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 117 adverse event reports in the FDA FAERS database where LONCASTUXIMAB TESIRINE-LPYL was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for LONCASTUXIMAB TESIRINE-LPYL

Side Effect Reports % Deaths Hosp.
Death 32 15.8% 32 3
Rash 17 8.4% 2 2
Pleural effusion 14 6.9% 3 4
Fatigue 13 6.4% 0 1
Oedema 13 6.4% 3 1
Photosensitivity reaction 12 5.9% 3 1
Disease progression 8 4.0% 5 0
Neutropenia 8 4.0% 1 1
Diarrhoea 7 3.5% 0 1
Infection 7 3.5% 3 2
Oedema peripheral 7 3.5% 3 4
Pericardial effusion 7 3.5% 1 2
Thrombocytopenia 7 3.5% 2 2
Diffuse large b-cell lymphoma 6 3.0% 6 1
Hepatotoxicity 5 2.5% 0 0

Other Indications for LONCASTUXIMAB TESIRINE-LPYL

Product used for unknown indication (60) Diffuse large b-cell lymphoma refractory (8)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

LONCASTUXIMAB TESIRINE-LPYL Full Profile All Diffuse large b-cell lymphoma Drugs LONCASTUXIMAB TESIRINE-LPYL Demographics LONCASTUXIMAB TESIRINE-LPYL Timeline